Rezo Therapeutics, Inc. — Form D/A
Rezo Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2025-08-18. The offering totals $80.1M, of which $68.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-08-18
- Form: D/A
- Accession: 0001853446-25-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $80.1M
- Amount sold: $68.1M
- Remaining: $12.1M
- Investors: 21
- Date of first sale: 2022-07-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-466228
Issuer
- Name: Rezo Therapeutics, Inc.
- CIK: 0001956559
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Phone: 415-310-4524
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Vineeta Agarwala | Director | Menlo Park, CA |
| Tiba Aynechi | Director | South San Francisco, CA |
| Norbert Bischofberger | Director | SAN FRANCISCO, CA |
| Simeon George | Director | Redwood City, CA |
| Derek Hicks | Director | SAN FRANCISCO, CA |
| Nevan Krogan | Director | SAN FRANCISCO, CA |
| George Scangos | Director | SAN FRANCISCO, CA |
| Jennifer Chang | Executive Officer | SAN FRANCISCO, CA |
| Derek Hicks | Executive Officer | SAN FRANCISCO, CA |
| Nevan Krogan | Executive Officer | SAN FRANCISCO, CA |
| Nevan Krogan | Promoter | SAN FRANCISCO, CA |
| Nadir Mahmood | Director | SAN FRANCISCO, CA |
| Nadir Mahmood | Executive Officer | SAN FRANCISCO, CA |
| Nadir Mahmood | Promoter | SAN FRANCISCO, CA |
| Sourav Bandyopadhyay | Executive Officer | SAN FRANCISCO, CA |
| Sourav Bandyopadhyay | Promoter | SAN FRANCISCO, CA |
Other filings by this issuer (2)
More